期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肾移植急性排斥反应相关生物学标记物的研究进展 被引量：3

下载PDF
导出
摘要 移植肾急性排斥反应是临床肾移植术后的重要并发症,寻找能早期诊断和预测移植肾急性排斥反应的生物学标记物是目前的研究热点.以往,免疫细胞与免疫分子作为肾移植排斥反应中的重要组成部分,一直是移植肾急性排斥反应的生物学标记物的重要来源.本文将就近年国内外热点的肾移植急性排斥反应的免疫细胞与免疫分子作一综述.
作者 赵鹏飞 张燊 苏泽轩
机构地区 暨南大学附属第一医院
出处 《国际医药卫生导报》 2010年第21期2571-2574,共4页 International Medicine and Health Guidance News
基金 国家高技术研究发展计划（863计划）项目（2007AA022006）
关键词 肾移植 急性排斥反应 免疫分子 免疫细胞
分类号 R699.2 [医药卫生—泌尿科学]
  • 相关文献

参考文献24

  • 1Mahic M,Yaqub S,Bryn T,et al.Differentiation of naive CD4+Tcells into CD4+CD25+FOXP3+regulatory T cells by continuous antigen stimulation[J].Leukoc Biol,2008,83 (5):1111-1117.
  • 2Pfortner S,Jeron A,Probst-Kepper M,et al.Signatures of human regulatory T cells:an encounter with old friends and new players[J].Genome Biol,2006,7(7):R54.
  • 3申升,刘东,黎程,吴家清,周结学,蒙善东,王健富,廖苏才,朱春丽,郑克立.外周血CD4^+CD25^(high)调节性T细胞比例变化在肾移植受者移植后免疫监测中的应用[J].中国组织工程研究与临床康复,2009,13(18):3425-3428. 被引量：3
  • 4Li XC,Wells AD,Strom TB,et al.The role of T cell apoptosis in transplantation tolerance[J].Curr Opin Immuno,2000,12 (5):522-527.
  • 5Marin LA,Muro M,Moya-QuilesMR,et al.Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients[J].Tissue Antigens,2006,67(2):117-126.
  • 6Carstens J,MarkussenN,MadsenM.The granule exocytosis and Fas/FasL igand pathways at the time of transplantation and during borderline and acute rejection of human renal allografts[J].Transplant Proc,2005,37 (8):3294-3297.
  • 7Miyagawa,HayashinoA,Tsuruyama T,Egawa H,et al.FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicato of rejection activity in human liver allografts[J].Am J Patho,2007,171 (5):1499-1508.
  • 8Morel O,Ohlmann P,Epailly E,et al.Endothelial cell activation contributes to the release of procoagulant microparticles during acute cardiac allograft rejection[J].Heart Lung Transplant,2008,27 (1):38-45.
  • 9苗芸,于立新,邓文锋,付绍杰,徐健,杜传福,王亦斌,李伟模,胡萍.CD95、CD95L mRNA在肾移植、肝移植以及肝肾联合移植受者外周血中表达的意义[J].器官移植,2010,1(2):95-98. 被引量：1
  • 10Atkinson EA,Barry M,Darmon AJ,et al.Cytotoxic T lymphocyte assisted suicide:caspase antivation is primarily the result of the direct action of granzyme B[J].Biol Chem,1998,273:21261-21266.

二级参考文献39

  • 1李静,肖波,张宁,周文斌,吴志国,谢光洁.从CD28/B7-1探讨雷公藤多甙治疗多发性肌炎的机制[J].中国现代医学杂志,2004,14(13):75-77. 被引量：7
  • 2刘小友,于立新,孙煦勇,袁谦.腹主动脉搭桥、硬膜外导管内撑法建立大鼠肾移植模型[J].中华实验外科杂志,2004,21(6):744-746. 被引量：15
  • 3刘雅峰,郑克立,戴宇平,王长希.移植肾组织中共刺激分子B7-1及相关蛋白的表达研究[J].中国现代医学杂志,2005,15(21):3264-3266. 被引量：3
  • 4唐帆,彭超,郑楠,褚建新.小鼠急性肾损伤后细胞再生的动态观察[J].上海交通大学学报（医学版）,2007,27(6):670-672. 被引量：2
  • 5Teppo AM, von Willebrand E, Honkanen E, et al. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1. Transplantation. 2001 ;71 (8): 1113-1119.
  • 6Perez RV, Huang CQ, Johnson JR, et al. Pretransplantation soluble adhesion molecule expression predicts outcome after living donor renal transplantation. Arch Surg. 2003;138(10):1113-1119.
  • 7Stepkowski SM, Chen W, Bennett CF, et al. hosphorothioate methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplant Proc. 2001 ;33(7-8):3705-3706.
  • 8Ortiz AM, Troncoso P, Kahan BD, et al. Prevention of renal ischemic reperfusion injury using FTY 720 and ICAM-1 antisense oligonucleotides. Transplant Proc. 2003;35(4):1571-1574.
  • 9Rouschop KM, Roelofs JJ, Rowshani AT, et al. Pre-transplant plasma and cellular levels of CD44 correlate with acute renal allograff rejection. Nephrol Dial Transplant. 2005;20(10): 2248-2254.
  • 10Ribeiron DS, David NE, Castro MC, et al. Contribution of the expression of ICAM- 1, HLA - DR and IL - 2R to the diagnosis of acute rejection in renal allograft aspirative cytology. Transpl Int. 1998;11(1 ):S19-S25.

共引文献11

同被引文献47

  • 1吕铁明,谭建明.转化生长因子β1基因型与移植肾慢性排斥反应的关系[J].中国医药生物技术,2007,2(1):28-31. 被引量：2
  • 2李川江,于立新,徐健,付绍杰,邓文锋,杜传福,王亦斌.转化生长因子β1基因多态性与慢性移植肾肾病的关系[J].南方医科大学学报,2007,27(4):535-537. 被引量：3
  • 3Caggiari L, Toffoli G,De Re V, et al. K1R/HLA combination associated with the risk of complications in celiac disease[J]. Int J Biol Markers, 2011,26(4) :221 - 228.
  • 4Tajik N, Shahsavar F, Poormoghim H, et al KIR3DLI + HLA - 13 Bw4lle80 and KIR2DSI + HLA- C2 combinations are both associated with ankylcxsing spondylitis in the Iranian poputation[J ]. Int J Immunogenet, 2011,38(5) :403 - 409.
  • 5周惠忠,黎磊石.肾移植排异反应的机理与诊断.国际泌尿系统杂志,1987,2:15-17.
  • 6Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal transplant survival. Lancet, 2001, 357: 1758-1761.
  • 7Ro H, Hwang YH, Kim H, et al. Association of polymorphisms of interleukin-8, CXCR1, CXCR2, and selectin with allograft outcomes in kidney transplantation. Transplantation, 2011, 91: 57-64.
  • 8Rosso FC, De Sandes TV, Sampaio EL, et al. Clinical impact of polymorphisms of transport proteins and enzymes involved in the metabolism of immunosuppressive drugs. Transplant Proc, 2009, 41: 1441-1455.
  • 9Grenda R, Prokurat S, Ciechanowicz A, et al. Evaluation of the genetic background of standard-immtmosuppressant-related toxicity in a cohort of 200 paediatricrenal allograft recipients: a retrospective study. Ann Transplant, 2009, 14: 18-24.
  • 10Ozdemir V, Kalow W, Tang BK, et al. Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics, 2000, 10: 373-388.

引证文献3

二级引证文献2

国际医药卫生导报
2010年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部